These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1363513)

  • 41. A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue.
    Skasko E; Paszko Z; Mazur S
    Neoplasma; 2005; 52(1):10-7. PubMed ID: 15739020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?
    Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S
    J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative analysis of p185(HER-2/neu) protein in breast cancer and its association with other prognostic factors.
    Valerón PF; Chirino R; Vega V; Falcón O; Rivero JF; Torres S; León L; Fernández L; Pestano J; Díaz-Chico B; Díaz-Chico JC
    Int J Cancer; 1997 Apr; 74(2):175-9. PubMed ID: 9133451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunometric assays of ras and c-erbB-2/neu overexpression in breast cancer: a pilot study.
    Pelizzola D; Malagutti R; Giovannini G; Indelli M; Carcoforo P; Piffanelli A
    Int J Biol Markers; 1999; 14(3):178-85. PubMed ID: 10569141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Breast carcinoma in pregnancy. Clinical, histological and immunohistochemical findings].
    Meden H; Marx D; Rath W; Tsikuras P; Kuhn W; Schauer A
    Zentralbl Chir; 1992; 117(4):216-9. PubMed ID: 1351330
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of the quantitative measurement of the oncoprotein p185(Her-2/neu) in a group of patients with breast cancer and positive node involvement.
    Bohn U; Aguiar J; Bilbao C; Murias A; Vega V; Chirino R; Díaz-Chico N; Díaz-Chico JC
    Int J Cancer; 2002 Oct; 101(6):539-44. PubMed ID: 12237894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. c-erbB2 expression in correlation to other biological parameters of breast cancer.
    Marx D; Schauer A; Reiche C; May A; Ummenhofer L; Reles A; Rauschecker H; Sauer R; Schumacher M
    J Cancer Res Clin Oncol; 1990; 116(1):15-20. PubMed ID: 1968902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relevance of p185 HER-2/neu oncoprotein quantification in human primary breast carcinoma.
    Bermont L; Algros MP; Baron MH; Adessi GL
    Breast Cancer Res Treat; 2000 Sep; 63(2):163-9. PubMed ID: 11097092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determination of ErbB2 protein in breast cancer tissues by different methods. Relationships with other biological parameters.
    Piffanelli A; Dittadi R; Catozzi L; Gion M; Capitanio G; Gelli MC; Brazzale A; Malagutti R; Pelizzola D; Menegon A; Giovannini G; Gardini G
    Breast Cancer Res Treat; 1996; 37(3):267-76. PubMed ID: 8825138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. p185 overexpression in 220 samples of breast cancer undergoing primary surgery: comparison with c-erbB-2 gene amplification.
    Dalifard I; Daver A; Goussard J; Lorimier G; Gosse-Brun S; Lortholary A; Larra F
    Int J Mol Med; 1998 May; 1(5):855-61. PubMed ID: 9852307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of p185 is not related to erbB2 amplification in ovarian cancer.
    Morali F; Cattabeni M; Tagliabue E; Campiglio M; Menard S; Marzola M; Lucchini V; Colombo N; Mangioni C; Redaelli L
    Ann Oncol; 1993 Nov; 4(9):775-9. PubMed ID: 7904177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation of c-erbB-2 protein expression with histologic grade, lymph node involvement and steroid receptor status in human breast tumors.
    Lampe B; Genz T; Maassen V; Mikorey S; Klosterhalfen T
    Arch Gynecol Obstet; 1992; 251(1):45-50. PubMed ID: 1347986
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measurement of erbB-2 oncoprotein in human breast cancers by ELISA.
    Nugent A; McDermott E; O'Higgins N; Fennelly JJ; Duffy MJ
    Biochem Soc Trans; 1992 Feb; 20(1):82S. PubMed ID: 1353039
    [No Abstract]   [Full Text] [Related]  

  • 55. [Measurement of C-erbB-2 protein in breast cancer tissue by enzyme-immunoassay: preliminary report].
    Narita T; Funahashi H; Sato Y; Imai T; Takagi H
    Nihon Geka Gakkai Zasshi; 1993 Jun; 94(6):661. PubMed ID: 8101962
    [No Abstract]   [Full Text] [Related]  

  • 56. c-erbB-2 and ras expression levels in breast cancer are correlated and show a co-operative association with unfavorable clinical outcome.
    Dati C; Muraca R; Tazartes O; Antoniotti S; Perroteau I; Giai M; Cortese P; Sismondi P; Saglio G; De Bortoli M
    Int J Cancer; 1991 Apr; 47(6):833-8. PubMed ID: 1672666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of immunohistochemical c-erbB-2 product localization pattern for prognosis of primary human breast cancer.
    Zschiesche W; Schönborn I; Minguillon C; Spitzer E
    Cancer Lett; 1994 Jun; 81(1):89-94. PubMed ID: 7912648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: cautions on evaluating p170(mdr-1).
    Liu B; Sun D; Xia W; Hung MC; Yu D
    J Natl Cancer Inst; 1997 Oct; 89(20):1524-9. PubMed ID: 9337349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues.
    Natali PG; Nicotra MR; Bigotti A; Venturo I; Slamon DJ; Fendly BM; Ullrich A
    Int J Cancer; 1990 Mar; 45(3):457-61. PubMed ID: 1968437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alterations of the c-erbB2 gene in human breast cancer.
    Zoll B; Kynast B; Corell B; Marx D; Fischer G; Schauer A
    J Cancer Res Clin Oncol; 1992; 118(6):468-73. PubMed ID: 1352298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.